The Beating Heart of Food Innovation ACCELERATOR · INNOVATION PARTNER · VENTURE CAPITAL Food innovation doesn’t fail for lack of ideas. It fails when execution doesn’t stick. At Eatable Adventures, we build from inside the food system, not as observers, but as builders. We turn ambition into outcomes through fast validation & acceleration, business deployment, and platforms/hubs that execute at scale. So the food system becomes safer, healthier, and more sustainable under real life constrains. We work across the full chain: Startups, Corporates, Governments, and Investors with one goal: results that hold up in operations and value creation. Proof we …

Type: NGO, Think-tanks, Ed, & Culture Activities: foodtech

Building communities. Enabling innovation. Connecting the life science ecosystem. We’re a non-profit on a mission to build meaningful communities to enable innovation and connect the life science ecosystem. BioEntrepreneur Club Building a start-up is no mean feat and the value of peer-to-peer support cannot be underestimated. So we’ve built a collaborative community exclusively for the founders and C-suite of early-stage life science companies in the UK, now with over 250 members. BioCapital Network Investment in all shapes and sizes is fundamental to growing the life science ecosystem. So we’ve established one of the largest investor communities, with over 300 members …

Type: Media Activities: deeptech biotech healthtech it services

Entrepreneurship is a continuous storm Calm/Storm is an exclusive founder network and boutique venture capital firm. We focus on talents, not industries. We believe in lifelong learning & personal growth, empowering entrepreneurs with unique access to successful founders. We are a fund built by founders for founders.

Type: Incubators & VCs

An independent European research group providing data-led advisory services on global economic and financial issues TAC ECONOMICS is a French independent leading provider of economic and financial consulting services with a strong expertise on country risk based on AI and data-driven solutions. Our team of experienced economists and data scientists specializes in providing cutting-edge data, models, and analysis to help our clients detect major risks and evaluate investment opportunities. Our commitment to AI and data-driven solutions is rooted in our pioneering work in the early 1990s, where we developed artificial intelligence tools to predict financial crises in emerging economies and …

3 similar entities Type: SMB Activities: fintech Technologies: A.I.

The European Society of Cardiology (ESC) brings together healthcare professionals from more than 150 countries, working to advance cardiovascular medicine and help people lead longer, healthier lives ♥️ Clinical Practice Guidelines, Educational Courses/Initiatives, ESC Journals Family, ESC Congress, and Cardiology

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech

Cross-Border Value Add and Expansion Capital for Technology Companies Atlantic Bridge is a global growth equity technology investment firm with over €1Bn of assets under management across eight Funds. The Funds invest in deep tech sustainable sectors such as Machine Learning, Digital Health, Computer Visioning, Industry 4.0, IoT and Big Data across Ireland, Europe and the US. Global investors in Atlantic Bridge Funds include Strategic Corporates, Sovereign Wealth Funds, Banks, Pension Funds and Family Offices. The experience and reputation of the investment team as both entrepreneurs and investors allows us to apply our proprietary “Bridge Model” to investments which accelerates …

Type: SMB Activities: fintech Technologies: A.I. A.I. - Image Processing A.I. - Machine Learning Data Analytics IoT

Applying pathbreaking science to transform the lives of patients with severe retinal neurodegenerative diseases GenSight Biologics is a clinical-stage biotechnology company discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system. GenSight Biologics’ pipeline leverages two core technology platforms, the Mitochondrial Targeting Sequence (MTS) and optogenetics for retinitis pigmentosa, to help preserve or restore vision in patients suffering from severe degenerative retinal diseases. GenSight Biologics’ lead product candidate, GS010, is in Phase III trials in Leber’s Hereditary Optic Neuropathy (LHON), a rare mitochondrial disease that leads to irreversible low vision and legal blindness in …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Our mission: find solutions for hearing disorders Sensorion is a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders Its clinical-stage portfolio includes one Phase 2 product: SENS-401 (Arazasetron) progressing in a planned Phase 2 proof of concept clinical study of SENS-401 in Cisplatin-Induced Ototoxicity (CIO) and, with partner Cochlear Limited, a study of SENS-401 in patients scheduled for cochlear implantation. Sensorion has entered into a broad strategic collaboration with the Institut Pasteur focused on the genetics of hearing. It has two gene therapy programs …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Biotech company producing biobased organic acids and derivatives via non-food biomass fermentation 🌿 AFYREN is a pioneering biotech company, developing innovative solutions for the production of high value-added biobased compounds. Our purpose is to “enable low-carbon, circular industry by providing biobased solutions built with our partners to benefit the environment”. Our Technology is based on a biomimetic fermentation process patented worldwide through 10 patent families 🔬 Our production model: AFYREN NEOXY, AFYREN’s first plant is a unique, low-carbon, zero-waste biorefinery that produces 7 100% biobased acids. It is located in Carling Saint-Avold (Grand-Est region, France) a strategic location set in …

116 similar entities Type: Startup Activities: biotech deeptech civictech cleantech greentech manufacturing Technologies: Bio sourced materials

Since its establishment in February 2011, Otsuka Medical Devices Co., Ltd. has focused on developing unique solutions that improve the health and well-being of patients whose medical needs and conditions cannot yet be fulfilled by existing treatment methods. To achieve our aspiration of becoming a pioneer in the medical device industry, we combine global R&D efforts with the technology and drug discovery know-how inherent within the Otsuka group’s heritage.

55 similar entities Type: SMB Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology

GFBiochemicals is a leader in manufacturing safe & sustainable plant-based bio-chemicals. 🌍🌱🧪 GFBiochemicals is a global innovator in manufacturing safe, sustainable, and high-performing bio-based alternatives to harmful petrochemical ingredients. With over a decade of research and more than 200 developed patents, the company has unlocked the potential of levulinate technology and its derivatives to accelerate the defossilisation of the chemical sector. Today, GFBiochemicals is shaping the future of industrial chemistry through its breakthrough platform: RE:CHEMISTRY empowering businesses to create everyday products that are safe and sustainable. Levulinic Acid, Application Development, R&D, Green Chemistry, Formulation Development, Biodegradable chemistry, Agrochemical, Personal care, …

Type: Startup Activities: manufacturing deeptech Technologies: Decarbonization

Transforming ideas into reality in the digital landscape. Netlight is an international digital consulting firm, helping leading companies to succeed in the digital landscape, from advice to implementation. Our ambition is to co-create and be an augmented partner to our clients as they explore the digital landscape. Our clients range from industry-leading enterprises to disruptive startups turning into unicorns. Trusted with their challenges, we have built a unique experience since 1999 in how to approach the uncharted digital landscape and go from idea to reality, together. We strive to be role models — conscious of positive change at the forefront …

Type: Large company

Microalgae-based bioactives for better living Created in 2007 near Montpellier-France, Microphyt develops and markets unique microalgae-based bioactives using breakthrough technologies and processes. Developed over 10 years, and endorsed by key customers, partners and investors, these bioactives are addressing the nutraceutical & cosmetic industry sectors. photobioreactor, microalgae, nutrition, biotechnology, Blue Future, nutraceuticals, Made in France, Cosmetics, innovation, better living, patented technology, natural ingredients, and bioactive compounds

75 similar entities Type: Startup Activities: biotech deeptech Technologies: Bio sourced materials

Meiogenix advances crop improvement through proprietary breeding technologies based on precise, targeted recombination. By unlocking the natural diversity of crops, we enable breeders to deliver elite varieties that help farmers meet the challenges of productivity, sustainability and disease resilience. genomics, homologous recombination, genetic diversity, biotech, and agriculture

Type: SMB Activities: deeptech biotech

Transforming how the world makes chemicals – sustainably produced bio-based chemicals through precision fermentation. DMC is a U.S. biomanufacturer seeking to transform how the world makes chemicals. The company leverages precision fermentation and synthetic biology to decarbonize chemicals, deliver more sustainable and natural food ingredients and supplements, and improve the security of global supply chains. It’s platform technology, Dynamic Metabolic ControlTM, simplifies biology, and enables predictable, robust, and more efficient fermentation. biotech, sustainability, fermentation, amino acids, metabolic engineering, specialty chemicals, bio-based chemicals, precision fermentation, dietary supplements, nutraceuticals, cosmetic actives, bio-based monomers, l-alanine, sustainable chemistry, and biotechnology

79 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

The biopharma world is here Endpoints is the biopharma world's leading source for breaking news, smart analysis and exclusive access. We cover the intersection of science, money and power in the world's most innovative industry, and are a part of the Financial Times' FT Specialist group. Biotechnology, News, Drug Development, and Pharmaceuticals

Type: Media

Securing Implant Placement Making Spine Surgery Safer SpineGuard is a French innovative medical company dedicated to the deployment and adoption of DSG® (Dynamic Surgical Guidance), powerful radiation-free real time sensing technology platform that spans a broad spectrum of skeletal applications from bone drilling instruments to automated placement of bone implants. Uniquely positioned to change the game in orthopedic robotic surgery. Devices, built with the DSG technology, give real-time audio and visual feedback to the surgeons to secure and streamline skeletal implant placement for the benefit of patients, surgeons, operating room staff and healthcare providers. The PediGuard probes are the only …

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

The circle of French IT department decision-makers, an extension of the IMA focused on IT transformation challenges The Next-Gen IT circle brings together IT/DSI/Cyber decision-makers from the 130 IMA member organizations on the subjects of developments in IT and Cybersecurity professions and technologies, in order to share good practices and recommendations, compare experiences and reflections, and accelerate their projects. _ Extension of the IMA (www.ima-dt.org - main French-speaking consortium of technological departments - 130 members including 3/4 of the CAC40) focused specifically on the evolution and transformation of IT and CyberSecurity, the "Next Gen IT" circle brings together all IT …

44 similar entities Type: SMB Activities: it services telecommunications Technologies: Cybersecurity

Innovation, instruments, machines sur mesure et solutions digitales pour l'industrie du futur Our mission: design, develop and manufacture custom-made machines, innovative equipment and product lines for industries of the future. Our competencies: design, 3D CAD, automatisation and supvervision, robotics integration, clean room integration, numeric axis, marking, datamatrix, RFID, vision and controls.... References: Sanofi, Fresenius Medical Care, Boehringer Ingelheim, bioMérieux, L'Oréal, Valéo, Michelin, Schneider Electric, Becton Dickinson, ST Microelectronics, Staubli, ITEN, Buashc+Lomb, Xfab, EFI Automotive, STILLA, Soitec, Ceva, Symatese Device, Bobst, IPSEN, Medtronic, ABL Europe, Catalent, Pfizer, Clariant, Aguettant, Service de Santé des Armées... Robotics integration, Sterile flexible welders, Automated assembly …

178 similar entities Type: SMB Activities: industry 4.0 manufacturing Technologies: Robotics Wireless

Index helps the most ambitious entrepreneurs turn bold ideas into global businesses. Index Ventures partners with exceptional entrepreneurs – those with unique insight who are intrinsically driven to make their vision a reality. We help them turn their bold ideas into global businesses, and through the companies they build, have a long-lasting and positive impact on the world around us. Index-backed businesses are supported by an experienced team of investors, strategists, and an extensive global network built over three decades of startup investing. Working side-by-side through the scale up journey, we forge deep and long-lasting relationships with founders and their …

40 similar entities Type: SMB Activities: fintech Technologies: A.I.

SOSV is the most active deep tech venture capital firm globally SOSV is the most active deep tech venture capital firm globally, investing at pre-seed (or at startup inception) supporting visionary founders intent on making a profound impact on human and planetary health. SOSV has three deeply resourced locations for founders in San Francisco (SOSV SF), New York (SOSV NY), and Newark (SOSV HAX). Each year, SOSV makes roughly 60 pre-seed investments of up to $550K each, as well as another 150 follow-on investments in deep tech companies. The pre-seed founders spend 4–6 months working side-by-side with SOSV General Partners …

Type: Incubators & VCs

Mapping the world's tech ecosystems About us We help our clients discover the world’s most promising companies through predictive intelligence. We place them at the forefront of innovation with industry-leading insights and benchmarks. We also make entire ecosystems more connected and help them unleash their full potential through data transparency. Our data Dealroom is the foremost data provider on startups, growth companies, and tech ecosystems around the globe. We combine machine learning and data engineering with robust verification processes and a strong network of ecosystems. These days, companies grow from seed stage to unicorn within a few years. Therefore historical …

60 similar entities Type: Startup Activities: fintech Technologies: Data Analytics A.I. A.I. - Machine Learning

Studying the mechanisms of rare genetic diseases and developing innovative therapies. TIGEM is a leading research institute dedicated to uncovering the molecular mechanisms of rare genetic diseases and translating these discoveries into innovative therapies, with a focus on conditions such as lysosomal storage disorders, metabolic liver diseases and inherited retinal dystrophies. Based in a renovated Olivetti industrial building in Pozzuoli, near Naples, TIGEM offers a 5,000 m2 campus with open-space laboratories, a large auditorium and several state-of-the-art core facilities supporting an international community of research groups. TIGEM advances fundamental and translational research on rare genetic diseases and accelerates the path …

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech healthtech

ProductLife Group (PLG) is a global service provider in Life Sciences, delivering end-to-end consulting and outsourcing services across the entire product lifecycle. With a presence in 150+ countries, own resources in 50+ countries, and a team of over 2,000 professionals, PLG acts as a one-stop-shop partner for the pharmaceutical, biotechnology, medical device, nutrition, and cosmetics sectors. Our mission is to support clients in accelerating innovation, ensuring compliance, and ultimately improving human health. From Product Development to Market & Patient Access, from Regulatory Affairs and Safety & Vigilance to Consulting & Digital, our global experts join forces to shape the future …

Type: SMB Activities: biotech deeptech healthtech regtech Technologies: A.I.

Novozymes has combined with Chr. Hansen to become Novonesis: linkedin.com/company/novonesis. This global biosolutions company of 10,000 people is transforming how the world produces, consumes and lives. In 30-plus industries, its biosolutions help businesses meet their needs and the needs of our planet. Novozymes was formed in 2000 when Novo Nordisk split into three companies: Novo Nordisk A/S, Novozymes A/S and Novo A/S. Novozymes was the world leader in biological solutions with a commitment to Rethink Tomorrow. It served 130 markets with enzymatic, microbial and advanced protein solutions. The company’s solutions enabled higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel …

Type: Large company

Where bio partnerships happen. 2,000 founders, investors & F500 BD. San Jose, May 4–7. The pharma BD teams, corporate venture arms, and startup founders who are actively looking to partner are all in one room at SynBioBeta — May 4-7 in San Jose. Last year, deals that would've taken years of cold outreach came together in four days. If your company is looking to license technology, find a development partner, or get in front of the startups defining the next decade of bio, this is where it happens. Startups, Conferences, Biotechnology, Synthetic Biology, Investments, Bioengineering, Biopharmaceuticals, Agriculture, Bioeconomy, News, and …

Type: Media

News and comment from the world of angel investing AngelNews is a news service for the early-stage investment market focusing on angel investing. marketing, publishing, deal flow, investment, entrepreneurs, events, venture capitalists, business angels, equity crowdfunding, tax efficient investing, IFAs, and private investors

Type: Incubators & VCs

Moving Forward Moving With a Purpose Portugal Digital is the country's transformation engine. Its purpose is to accelerate Portugal, without leaving anyone behind, and to highlight this mission in the world. How? Through the digital empowerment of people, the digital transformation of businesses and the digitalization of the Public Administration.

Type: Public Activities: it services

EryPharm is a biotech start-up company dedicated to the development and the operation of a large-scale process for the production of Red Blood Cells from stem cells. The technology has been developed by Dr. Luc Douay and his team at the Paris Sorbonne university. You can contact EryPharm through our website: http://erypharm.com/contact.html Or you can contact Loïc Tron directly: www.linkedin.com/in/loictron

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

ELSAN, the leading group in private hospitalization in France, today has more than 28,000 employees and 7,500 private doctors who practice in the group's 217 establishments and centers. They care for more than 4.8 million patients per year. Our mission: to offer everyone quality, innovative and humane care. Our purpose: Acting for the health of all, in the heart of the territories. Health establishments

Type: Media Activities: healthtech

We help young people find their route through education into employment, and provide employers access to future talent We connect young people to a world of career possibilities, inspire them to dream big and empower them to fulfil their potential. We want to equip young people with the experience and skills they will need to succeed in their career of choice, and enable businesses to recruit skilled workers locally. We bridge the gap between these two worlds and help them work together and achieve more. We deliver the skills service for the Greater Cambridge Partnership, linking schools and businesses to …

Type: NGO, Think-tanks, Ed, & Culture Activities: hrtech

Invested Investors Merieux Equity Partners is a multistage investment manager specialized in the healthcare & nutrition sectors via two dedicated platforms: Venture and Growth/Buyout. As an independent General Partner - registered under the French Financial Markets Authority AMF ("Autorité des Marchés Financiers") - Merieux Equity Partners currently manages 5 main funds, representing more than €1 billion of Commitments, and has supported over 45 companies in Europe and North America since its creation - in Venture Capital and Growth/Buyout. Our passion is to work alongside entrepreneurs and companies with an ambitious growth plan, offering them privileged access to our sector-expertise and …

31 similar entities Type: Startup Activities: fintech Technologies: SaaS

Premier network of co-working spaces for life science startups BioLabs are the premier co-working spaces for life science startups- unique places where you can test, develop and grow your game-changing ideas. As entrepreneurs and investors ourselves, we have first-hand experience with the pain-points biotech start-ups face. Our goal is to change how scientific entrepreneurs do business by building an ecosystem that empowers bioinnovators to grow quickly, while maximizing capital efficiency. coworking, biotech, and pharmaceutical

Type: Media

French Accelerator dedicated to innovation in oncology MATWIN (Maturation & Accelerating Translation With INdustry) est un programme accélérateur pour développer la recherche translationnelle en cancérologie et faciliter le transfert des innovations vers les patients. Son objectif principal est d'accompagner des projets innovants (issus de laboratoires académiques ou portés par des startups) et présentant un fort potentiel de développement en favorisant des partenariats précoces. Le programme s’appuie sur un partenariat avec de grands laboratoires engagés en oncologie (Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Exact Sciences, Gilead, GlaxoSmithKline, Nanostring Technologies, Novartis, Pfizer, Pierre Fabre, Roche, Sanofi) et l’ensemble des acteurs soucieux de …

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech

Supporting scientists and entrepreneurs launching technologies that extend the longevity of people and planet LifeX invests in the two largest sectors in the world, People and Planet, where Software suddenly matters. Software is changing the process of commercializing and discovering breakthroughs for human (bio/health) and planetary (climate) longevity: * Faster adoption - means commercialization and monetization of breakthroughs using internet tech: Web3, marketplaces, payments/fintech, DAOs, networks, privacy layers, branding, new business models, operators, ... * Faster innovation - means new platforms and infrastructure: SaaS, analytics, visualization tools, APIs, data as-a-service, OSs, workflow automation, simulations, AI / prediction tools, design and …

35 similar entities Type: Startup Activities: it services Technologies: A.I.

Natural, tissue-based solutions for refractive surgery Allotex develops natural, tissue-based solutions for refractive surgery. Precision-shaped collagen implants are designed to integrate naturally with the eye, enabling safe additive procedures that fit seamlessly into modern surgical workflows, with proven clinical outcomes. ophthalmology

Type: Startup Activities: it services

Driving immune-mediated therapeutic innovation for women. Freya Biosciences is a clinical-stage immunology company developing therapies treating inflammation and immune dysregulation in conditions that affect women. Freya is advancing a diversified pipeline, including two first-in-class Phase 2-ready assets for IVF-related embryo implantation failure and preterm birth. Freya’s science is powered by its DyscoverTM platform, a unique multi-omics data science platform built on a biobank of 1,000+ clinical samples derived from both observational and randomized, placebo controlled trials. This provides deep insights into disease pathway associated markers, allowing for de-risked target identification and patient stratification. Backed by a world-class team with a …

15 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

Developing inobrodib (CCS1477), first-in-class p300/CBP inhibitor to treat specific cancers. Inobrodib is the first small molecule drug in the clinic targeting twin proteins p300 and CBP. It is formulated as a capsule taken orally. p300/CBP are twin (paralogue) acetyl transferases, and importantly, gene activating proteins that are known to play an important role in the progression of certain cancers. CellCentric’s pioneering drug is in Phase I/II clinical trials to evaluate its effectiveness to treat specific solid tumours, as well as haematological malignancies (blood cancers). These represent major clinical unmet needs, delivering a new therapy for people with cancer, who otherwise …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Targeting the root cause of neurodegeneration Asceneuron is a clinical stage biotech company focused on the development of orally bioavailable therapeutics for debilitating neurodegenerative disorders with high unmet medical need. The pipeline reflects our ambition to develop treatments for a wide a range of neurodegenerative diseases including orphan tauopathies, Alzheimer’s and Parkinson’s disease. Asceneuron has two clinical stage small molecule O-GlcNAcase inhibitors in development for the treatment of proteinopathies including Parkinson’s Disease, Alzheimer’s disease and related disorders. Asceneuron is a privately held company financed by a renowned syndicate of investors consisting of Sofinnova Partners, M Ventures, SR One, Johnson & …

3 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We make the circular #bioeconomy happen The Italian Circular Bioeconomy Cluster SPRING – Sustainable Processes and Resources for Innovation and National Growth - has the objective of triggering the development of biobased industries in Italy, through an holistic approach to innovation, aimed at revitalising Italian industries in the name of environmental, social and economic sustainability. The purpose is to stimulate research and investments in new technologies, in constant dialogue with local stakeholders, and to pursue the European Commission most recent policies on bioeconomy.

Type: NGO, Think-tanks, Ed, & Culture Activities: greentech cleantech

Life's a Link 💜 Multiple Lnks for your Bio 💜 1,500,000+ creators 💜 Black-woman owned & led 💜 BIPOC, LGBTQIA+, Disability activists for Equity: DM me to get a free Activist Pro instagram, social media, celebrities, influencers, agency, youtube, weibo, twitter, link in bio, tiktok, link page, multi accounts, insta link, insta page, shortest url, Lnk In Bio, nocode, and linkbio

Type: Startup Activities: martech

Turbine is virtualizing biological experiments with AI to accelerate drug discovery & enhance clinical translatability. Turbine is virtualizing biological experiments with AI to accelerate drug discovery and enhance clinical translatability. We’ve spent the last decade building virtual disease models designed to ultimately become second only to the patient in predicting drug response. By simulating how cells and tissues behave under treatment, Turbine helps pharma identify the right therapeutic ideas smarter and faster, cutting years of dead-end research and reducing Phase II failure caused by poor efficacy. Scientists can now run billions of virtual experiments to uncover risk, design smarter trials, …

Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology

Leading the way for leaflet modification Pi-Cardia is a medical device company and market leader in the development of a broad portfolio of leaflet modification solutions for treating heart valves. The company has years of knowledge and expertise accumulated in degenerated valves, including calcification patterns, mode of valve failure, and impact of various methods of leaflet modification. ShortCutTM is designed to provide a safe, simple, and effective way to split leaflets of a pre-existing valve to enable TAVR in patients at risk for coronary obstruction and may assist in preserving coronary access. Medical Device, Aortic Stenosis, Precautions Catheter-System, Cardiovascular, leaflet …

Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Pioneering treatments for Stargardt disease and Usher 1B, addressing the root cause of the disease AAVantgarde is a clinical stage, biotechnology company advancing best-in-class therapies for patients with inherited retinal diseases (IRDs). With a strong foundation in translational science and a commitment to clinical excellence, AAVantgarde is working to bring transformative therapies to patients. Gene Therapy, Ophthalmology, and Rare diseases

65 similar entities Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology

Seamless Therapeutics is overcoming the boundaries of gene editing by unlocking the full potential of recombinases. Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach to restore health in patients with severe conditions in a safe and precise manner. Our technology platform unlocks the reprogramming of recombinases, a highly versatile class of enzymes. We are applying our proprietary know-how to develop a pipeline of disease-modifying product candidates across a broad spectrum of indications to expand the therapeutic potential of gene editing.

40 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Natural Food Colors Phytolon offers natural food colors, uniquely positioned to comply with the consumers needs for healthy food, and with the industry requirements for cost-efficiency and high quality. Phytolon leverages a novel and sustainable fermentation-based technology by which betalain natural colors are produced in baker's yeast. food colors, natural ingredients, yeast, fermentation, sustainability, biotechnology, and foodtech

28 similar entities Type: Startup Activities: foodtech Technologies: Bio sourced materials

Supercharging Consumer-Powered Climate Innovation Regeneration.VC is a global venture capital firm investing in Consumer ClimateTech innovation. Our investment strategy targets early-stage companies demonstrating asymmetric return potential by insetting environmentally aligned solutions within consumer value chains. Our mission is to realize abundance within planetary boundaries through regenerative consumer value chains. Have an innovation ready to supercharge? Submit here: https://form.fillout.com/t/dDYPidgNx4us Circular Economy, Sustainable Investing, Venture Capital, Consumer, Climate Tech, Regeneration, and Consumer ClimateTech

45 similar entities Type: Startup Activities: cleantech greentech Technologies: Decarbonization

Treating the individual, not just the disease, through personalized and optimized dosing. We need to shift to a world where we treat the individual, not just the disease. Our inventions work in combination with medicine to deliver personalized, optimized dosing, to provide bespoke universal healthcare access and improve outcomes for patients with chronic diseases. Closed Loop Medicine is a TechBio company developing combination prescription drug + software products, with the aim of bringing forward the promise of precision care. Our proprietary technology platform facilitates personalized drug dose optimization through integration of medicines and software with patient-led digital experiences and closed …

12 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Mission Therapeutics is a private, drug discovery and development company focused on selectively targeting deubiquitylating enzymes to treat diseases of high unmet need. Mission has built a world-leading platform for the discovery and development of first-in-class, small-molecule drugs that selectively target deubiquitylating enzymes (DUBs) – an emerging, and hitherto intractable, drug class that is attracting significant commercial interest as the potential ‘Next Kinase Area’. Mission’s DUB platform is yielding a rich pipeline of novel therapeutics for the benefit of patients across therapeutic areas. Mission’s strategy is to create value by advancing its pipeline programmes through early clinical development, and preferentially …

17 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Helping scientists solve the world's most pressing problems with faster, more powerful experiments. Synthace is an end-to-end software solution built to enable biologists run more powerful, high-dimensional experiments and get to biological insight faster. It allows scientists to design, plan, and automate multifactorial experiments in a single place, then automatically gather and structure data and metadata, and analyse multivariate datasets with ease. Life Sciences, Lab Automation, Scientific Consulting, Design of Experiments, Drug Discovery, Assay Development, Software Engineering, and Drug Discovery

57 similar entities Type: Startup Activities: biotech deeptech Technologies: SaaS

European venture with a Silicon Valley mindset. We take risks on brilliant people and products. We work with founders on a mission to change the one thing they think is fundamentally broken in the world. We welcome young or first-time founders who are technical or domain experts in their field. Our focus is finding Europe’s best early stage tech startups and building them into large revenue, category-defining companies. We believe great companies are built by great teams, not by venture capitalists. Some might call our approach old-school. We lead pre-seed or seed rounds. We invest at fair terms and reserve …

13 similar entities Type: Startup Activities: fintech

Precision-Guided Therapeutics Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company that is harnessing the power of bicyclic peptides and leveraging Nobel Prize-winning science to develop a new and differentiated class of medicines to treat cancer and other diseases. Bicycle® molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycle molecules attractive candidates for drug development. The company is evaluating zelenectide pevedotin, previously BT8009, a Bicycle® Toxin Conjugate (BTC®) targeting Nectin-4, a well-validated tumor antigen; BT5528, a BTC …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Connecting an exclusive community of operational leaders in the private capital fund industry. As the private capital fund industry moves into a new phase of maturity and institutionalisation, the pressure and complexity faced by operational professionals is increasing exponentially. ‘The Drawdown’ offers exclusive access to an expert and supportive network where connections, valuable insight and best practice are shared, including The Drawdown Awards, Summer and Winter Operational Leaders’ Summits as well as focused invitation only events. We are empowering our members to succeed in this complex environment and to play an instrumental role in shaping the future of our industry. …

Type: Media Startup Activities: entertainment Technologies: Data Analytics

Crescendo Biologics - The T cell Enhancing Company Crescendo Biologics is a private, clinical stage immuno-oncology company developing novel, targeted T cell enhancing Humabody® therapeutics. Leading its proprietary pipeline, Crescendo Biologics has developed CB307, a novel half-life extended CD137 x PSMA Humabody for the selective activation of tumour-specific T cells exclusively within the tumour microenvironment. CB307 is designed to achieve a longer lasting anti-cancer effect whilst avoiding systemic toxicity, and the clinical programme for CB307 is underway in patients with PSMA positive solid tumours (NCT04839991). CB693 is a half-life extended CD137 x MSLN Humabody and is the second proprietary clinical …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Worldwide Mass Spectrometry & Transatlantic Life Science Business News https://t.co/dFBSfg8Zmb, https://t.co/6AvoAqaGQh, https://t.co/znABFjUO2M

Type: Media

Innovating the next generation of sustainable foods and feeds NoMy is a fermentation technology company transforming food industry side streams into high-value ingredients, using the power of fungi. Our fungal fermentation technologies are proven, scalable and cost-effective. Tiny microbes. Huge impact. fermentation, circularity, alternative proteins, biomaterials, bioscience, and regenerative

35 similar entities Type: Startup Activities: foodtech Technologies: New Materials

The startup discovery engine. Harmonic is the complete startup database. Used by hundreds of leading investors like Khosla, Lightspeed, and Founders Fund and GTM teams like OpenAI, Anthropic, and Google to find the next generation of startups and founders.

Type: Startup Activities: it services Technologies: Data Analytics

Discovering the relationships at the heart of biology to cure disease. We are an end-to-end biotech developing transformational medicines, with technology at our core. Our ambition is to understand human biology in an unprecedented way; discovering therapies that will treat some of life's most devastating diseases. We leverage single-cell and multi-omics measurements directly from patient tissue, functional assays and machine learning to drive disease understanding — from cause to cure. Medicines born from high-resolution biology, machine learning and clinical insights. Our Lab-in-the-Loop seamlessly integrates single-cell analysis, genomics and machine learning. We have developed powerful technologies which we apply to select …

85 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Real Leather, Reinvented Leather is loved. Leather is luxury. Leather is everywhere. Unfortunately, making leather is also polluting, challenging and controversial. Qorium creates beautiful, premium, and authentic leather without compromise. Cutting-edge science empowers us to dramatically reduce the vast impacts of today’s leather industry without quality reductions. By removing the cow from leather production, Qorium’s material has minimal climate impacts, low water and chemical usage, no land use, and no animal impacts. Simply put, Qorium reinvents leather. Better product. Better planet. Biotechnology, Cell cultured leather, Leather, Cell grown Leather, Sustainable Leather, and Animal free Leather

Type: Startup Activities: greentech cleantech Technologies: Synthetic Biology

Advancing Glycan Mediated Therapy GlycoEra is developing biologics to selectively target the root cause of many autoimmune diseases: a specific circulating protein (autoantibody). Our approach enables us to degrade targets rapidly, selectively, and deeply while avoiding broader dampening of the immune system. This offers many potential benefits over existing broad-spectrum immune-suppressing therapies, including an improved safety profile and the potential for earlier disease intervention – which could improve patient quality of life, limit long-term complications and lower overall healthcare costs. Our best-in-class, extracellular degrader BiNDTM platform (Biologic Natural Degrader), allows us to target and rapidly, deeply degrade any circulating protein …

21 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

The surfaceome company. DISCO’s pioneering surfaceome mapping platform transforms the current approach of target discovery for large molecule R&D. The technology identifies proteins and protein communities across the entire cancer cell surface in a scalable manner, thus addressing the need for target candidates for both mono- and bi-specific antibodies. These insights enable the development of a multitude of cancer-selective therapies, with the potential to boost efficacy and reducing side effects for patients.

27 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Fixing housing and healthcare with agentic AI to improve how we live. Fixing housing and healthcare with agentic AI to improve how we live. AI, Automation, Housing, Machine Learning, Conversational AI, and agentic AI

68 similar entities Type: Startup Activities: it services Technologies: A.I. Generative A.I. A.I. - Machine Learning A.I. - Natural Language Processing SaaS

A consortium of healthcare, academic and industry partners working to develop & deploy AI systems across the NHS. The Artificial Intelligence Centre for Value Based Healthcare is one of five Centres of Excellence, established as part of the UK Government’s Industrial Strategy Challenge Fund and delivered through UKRI. Led by King’s College London and based at St Thomas' Hospital, the Centre brings together an ambitious consortium of academic, health and industry partners and a growing cohort of small-medium enterprises in the UK. Together, we are developing new diagnostic and treatment solutions that will improve patient outcomes and increase NHS efficiencies. …

56 similar entities Type: SMB Activities: healthtech deeptech Technologies: A.I.

A new culinary tradition Novameat is pioneering a new generation of protein cuts, specifically created for food makers. We challenge the limitations of conventional plant-based alternatives, which often impose constraints on culinary creativity. Our philosophy is rooted in the belief that true culinary culture is about exploration, not restriction – the pursuit of the perfect bite, not the adherence to a rigid recipe. We achieve this by combining natural ingredients with advanced texturing technology to craft protein cuts that inspire gastronomic innovation. Our commitment to quality is reflected in our gentle, low-temperature, low-pressure process, which preserves the full flavour, aroma, …

47 similar entities Type: Startup Activities: foodtech manufacturing Technologies: 3D Printing Bio sourced materials Synthetic Biology

Creating next-level therapies for inflammatory skin and joint diseases with Nanobody® science MoonLake Immunotherapeutics AG is a clinical-stage biopharmaceutical company leveraging revolutionary Nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases. Immunotherapy, inflammatory skin & joint diseases, partnering, IL17A / F, #MLTX, #Nanobody, #HS, #PsA, and #IL17

Type: Startup Activities: deeptech biotech

Next-generation, engineered monocyte immunotherapy for treating cancer Signadori Bio, is a preclinical-stage biopharmaceutical company developing a next generation, off-the shelf, in vivo engineered, monocyte immunotherapy platform to treat solid tumours. Founded by Dr Jean-Luc Perfettini and Professor Nathalie Chaput, and based on research conducted at Gustave Roussy, Signadori’s approach aims to overcome the challenges of the tumour microenvironment by harnessing the immune potential of gene-modified monocytes. Signadori is based in Paris and backed by Sofinnova Partners (Paris) and InVivo Partners (Barcelona). Immuno-Oncology and In-vivo Engineered Monocytes

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Introducing the next generation microwave ablation device for cancer treatment HEPTA Medical is developing a unique minimally-invasive non surgical treatment modality for early-stage cancers.

Type: Startup Activities: deeptech healthtech

“For us, music played live has more than a role of Amande Mielmusic is a performing arts company based out of Toulouse, France.

Type: Startup Activities: entertainment

The “Super Cho”, 2 street artists who decided in 2005 to start their company. One goal: to bring unique, impressive and, above all, incredibly funny shows to street and stage audiences. The geniuses of the international scene Super-Kev and Super-Had present their show videos, photos, street artist partners and offer you the opportunity to attend the greatest super show of all time. The Super Cho are street arts on the table, so everyone on stage in the name of a superhero! Light show, Fire show, fire juggling, and fireworks

Type: Startup Activities: entertainment

Enabling drug delivery to the brain. TheraSonic is revolutionizing the treatment of brain diseases by enhancing non-invasive drug delivery to the brain using focused ultrasound technology. Our innovative approach aims to transform neurological care and improve patient outcomes. --- TheraSonic révolutionne le traitement des maladies cérébrales en améliorant la délivrance de médicaments dans le cerveau grâce à des ultrasons focalisés non-invasifs. Notre approche innovante vise à transformer les soins neurologiques et à améliorer les résultats pour les patients.

Type: Startup Activities: healthtech deeptech biotech Technologies: Synthetic Biology

A community-focused approach to trusted data sharing in the mobility, transportation, and tourism industries EONA-X is a groundbreaking initiative in data sharing. We’re breaking silos and setting the basis of a new European data economy. It’s a new frontier, and we are leading the way by building trust through decentralized, open-source architecture. Our ecosystem of partners with shared goals streamlines mobility, transportation (including logistics), and tourism. We ensure these areas are secure and open so individuals and public/private entities can maximize data space for the common good. Renault, Amadeus, Groupe ADP, Air France-KLM, ACCOR, SNCF, and Aéroport Marseille Provence are …

Type: Startup Activities: it services transporttech smart city Technologies: Data Analytics

From preclinical hope To clinical proof, without the guesswork. Scienta is a deeptech company advancing translational research in immunology. Scienta develops EVA, the first AI foundation model purpose-built for translational prediction in immune-mediated diseases. EVA addresses a critical challenge in pharma R&D: the preclinical–clinical gap, where fewer than 10% of immune drug programs translate successfully to humans. Built on more than 3 billion multimodal data points across 30 diseases and 70 tissues, EVA uses a biology-first architecture designed to reason like an immunologist. It converts early experimental signals into predicted patient outcomes, with explainable outputs such as pathway-level activity and …

Type: Startup Activities: biotech deeptech Technologies: A.I.

Functional, sustainable, delicious fermentation dairy proteins. We are a French biotechnology company developing cutting-edge precision fermentation techniques, dedicated to take part in the environmental transition within the dairy production sector. Our innovative technology enables the production of dairy proteins without the need for animals, significantly reducing the ecological footprint. By providing our clients with cutting-edge, sustainable ingredients, we empower them to create a diverse range of dairy products identical to those you already love, both environmentally conscious and nutritionally rich. Join us on our journey to shaping a future where ethical dairy alternatives are complementary to conventional farming and contribute …

12 similar entities Type: Startup Activities: biotech deeptech Technologies: Decarbonization

Next-generation cancer treatment bringing the immune system one step ahead of cancer 🧬🟣 Brenus Pharma is a pioneering clinical stage biotech aiming to prevent cancer recurrence, the main challenge for solid tumors - causing 10M deaths each year worldwide. We developped a next-generation cancer treatment, thanks to our “off-the-shelf” therapeutic platform. Our lead candidate is a proteomic-driven immunotherapy targetting colorectal cancer (CRC), the 2nd deadliest cancer worldwide. - Our allogeneic platform generates therapeutics that efficiently educate the immune system, with more potent, diverse and novel targets than any existing therapies. (Characterized by advanced multiomics technologies) - We overcome limitations of …

163 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

The best thermal barriers for batteries, Aerospace/Defense and electronics. Enersens is a deeptech specialized in silica aerogel-based thermal insulation. Our killer product is SkogarR, a range of composite materials made of fibres and aerogel. SkogarR is used as thermal barrier and fire protection for batteries, Aerospace & Defense applications, electronics, etc. Silica Aerogel, High-performance Insulation, EV, Battery, Electric Vehicle, Aerogel blanket, Thermal runaway, Safety, Aerospace, Defense, Thermal Barrier, and Decarbonation

Type: Startup Activities: industry 4.0 manufacturing Technologies: Batteries New Materials

Scale drug discovery with quantum-inspired physics and generative AI AQEMIA is a drug invention company dedicated to novel medicines — never me-toos — tackling major diseases such as oncology. Our physics-based, generative AI platform invents drug candidates beyond the reach of traditional R&D, without dependence on experimental data. We are building a rapidly expanding portfolio of proprietary programs, alongside collaborations with top pharmaceutical companies. Multiple discovery successes are already achieved, with lead programs progressing through in vivo optimization. AQEMIA is part of the French Tech 120 program, which supports the most promising scale-ups in France with global impact potential. AQEMIA …

Tags: FrenchTech120 Type: Startup Activities: deeptech healthtech Technologies: A.I. Generative A.I. Synthetic Biology

Pioneering bio||intelligence for a healthier and sustainable future. Spartha Medical harnesses AI-driven bio||intelligence to engineer advanced biopolymer-based active interfaces with inherent antimicrobial, anti-inflammatory, and biocompatible properties. Our technology platform integrates biological data analysis and adaptive AI to design dynamic microstructures that neutralize pathogens, reduce infection risks, and enhance safety across medical devices, textiles, and industrial surfaces. Aligned with the One Health framework, we address interconnected human, animal, and environmental health challenges by preventing antimicrobial resistance, mitigating cross-species infections, and promoting sustainable material innovation. Committed to the UN Sustainable Development Goals (SDGs), we advance SDG 3 (Good Health), SDG 9 (Industry …

16 similar entities Type: Startup Activities: deeptech healthtech manufacturing Technologies: New Materials Synthetic Biology

Abivax is a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Abivax is currently evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. Abivax also plans to initiate a Phase 2a clinical trial of obefazimod in patients with Crohn’s disease. Obefazimod is an investigational, orally administered, once-daily therapy, which we believe has the potential to be a differentiated treatment option for inflammatory bowel diseases. It is the first and only molecule …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

1st secure platform for teleexpertise and collaborative eDiagnostics for healthcare practitioners and establishments. Rofim is a telemedicine platform connecting healthcare professionals in hospitals and in the city, facilitating diagnosis and improving patient care. It is based around teleexpertise, teleconsultation, assisted teleconsultation, e-RCP, oral and dental teleexpertise and Communicating Cancerology File. Bringing together 1,800 establishments and more than 80,000 doctors, Rofim has exceeded 2 million annual procedures in 2025. Created by doctors for doctors, the Rofim solution is supported by a committee of 40 healthcare professionals. A Mission-driven company since 2023, Rofim has this purpose at the heart of its strategy: …

Type: Startup Activities: healthtech Technologies: SaaS

CorWave develops and manufactures innovative implantable blood pumps based on a breakthrough membrane technology. CorWave is a French company developing innovative cardiac assist devices. CorWave’s wave membrane pump is a breakthrough technology that differs from today’s commercially available left ventricular assist devices (LVADs) by its physiological operation, designed to mimic a pulse and blood flow rates similar to those of a healthy heart. Ultimately, CorWave’s membrane pump technology is expected to reduce the complications associated with current devices and improve the management of heart failure patients. A member of the French Tech 120, CorWave was founded in 2012 by start-up …

Tags: FrenchTech120 Type: Startup Activities: deeptech healthtech manufacturing nanotech Technologies: Synthetic Biology

Beyond the people you want, get the people you need PEAK LIFECYCLES HR is an international Executive Search and Talent Management company dedicated to Global "Care environment"​ markets and their stakeholders. Placing the analysis of the business life cycle, and that of products, skills, and projects at the heart of its activity, Peak Lifecycles'​ unique, innovative expertise is founded on its anticipation of market requirements. OUR OFFERS: Executive Search, Talent Management, Organizational audit, Executive Coaching We also developed an offer dedicated to Startups and their lifecycles. PEAK LIFECYCLES HR conducts confidential executive search assignments. All official communications are made directly …

6 similar entities Type: Startup Activities: hrtech biotech deeptech healthtech

Founded in 2003, LinkedIn connects the world's professionals to make them more productive and successful. With more than 1 billion members worldwide, including executives from every Fortune 500 company, LinkedIn is the world's largest professional network. The company has a diversified business model with revenue coming from Talent Solutions, Marketing Solutions, Sales Solutions and Premium Subscriptions products. Headquartered in Silicon Valley, LinkedIn has offices across the globe. Online Professional Network, Jobs, People Search, Company Search, Address Book, Advertising, Professional Identity, Group Collaboration, and Recruiting

Type: Large company Activities: hrtech

The real-time in vivo cellular imaging platform that revolutionizes the way physicians diagnose and treat patients. Mauna Kea Technologies is a global medical device company that manufactures and sells Cellvizio®, the real-time in vivo cellular imaging platform. This technology uniquely delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time, assess point-in-time reactions as they happen in real-time, classify indeterminate areas of concern, and guide surgical interventions. The Cellvizio platform is used globally across a wide range of medical specialties and is revolutionizing the way physicians diagnose and treat patients — making a transformative …

Type: SMB Activities: healthtech deeptech Technologies: A.I.

Innovative personalized therapies targeting TREM-1 for life-threatening inflammatory syndromes such as septic shock Inotrem is a French biopharmaceutical company founded in 2013, with offices in Paris and a technology center in Nancy (France). Our mission is to improve public health by developing a new class of therapeutic solutions targeting the immunological pathway TREM-1 with a personalized medicine approach to manage life-threatening inflammatory syndromes with high unmet medical need. TREM-1 is a key amplifier of inflammatory responses implicated in various diseases such as septic shock, vaso-occlusive crisis in sickle cell disease, or hemorrhagic shock. Our lead drug candidate nangibotide has shown …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Leverage Real World Evidence in oncology Gimli empowers medical professionals to structure medical data. We extract and structure data directly from the EMR to streamline RWD, allowing the generation of strong RWE. Gimli is a Startup working with university hospitals, pharmaceutical companies, data analytics providers, and startups. Gimli has been acquired by Resilience in 2024.

Type: Startup Activities: healthtech deeptech Technologies: Data Analytics

Ensemble on est encore plus forts RUN ODYSSEA is a civic & social organization company based out of L'Etang Sale, La Réunion, France. cancer du sein, accompagnement des malades, prévention, and sport & santé

Type: NGO, Think-tanks, Ed, & Culture Activities: entertainment

Sustainable, healthy and delicious cultivated meat 🌎🍴 VITAL MEAT is a cultivated meat start-up based out of Nantes, France 🇫🇷 Our mission is to reduce human impact on the environment by providing HEALTHY, DELICIOUS, ETHICAL and SUSTAINABLE meat to billions of people 🌎 Thanks to our scalable technology and a cost effective process, we are gearing up to commercialize our first chicken product 🐔!

39 similar entities Type: Startup Activities: manufacturing greentech cleantech Technologies: Decarbonization

Artificial intelligence serving clinical biology Kiro is a fast-moving startup developing solutions for better patient care, powered by artificial intelligence. We aim at improving everyone’s health by supporting patients and doctors with understandable and relevant information. We believe that medical biology is at the heart of healthcare. It contributes greatly to the diagnosis, treatment and prevention of diseases. Our mission is to foster the interactions between laboratories, health professionals and patients, to go beyond results in patient care thanks to new technologies and artificial intelligence. Since its inception, Kiro has worked in close partnership with clinical biologists, doctors and medical …

26 similar entities Tags: FrenchTech2030 Type: Startup Activities: healthtech biotech Technologies: A.I. Synthetic Biology

Advancing prenatal ultrasound screening with AI At BrightHeart, we believe every single fetal ultrasound screening exam should be performed with the highest level of accuracy, so each mother and baby receive the highest possible quality of care.

57 similar entities Type: Startup Activities: it services healthtech Technologies: A.I.

Resolving cancer's complexity through the power of targeted drug combinations ABOUT US Mosaic Therapeutics is an oncology therapeutics company delivering precision medicines for patient groups with few targeted treatment options today. The company’s main mission is to tackle cancers with substantial unmet need by reinventing the traditional approach to target and drug discovery - leveraging our differentiated dual technology platform to advance novel combination therapies. Born out of pioneering research at the Wellcome Sanger Institute in collaboration with the Netherlands Cancer Institute, and anchored around a proprietary platform that has seen 20 years of fine-tuning and development, Mosaic has active …

172 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

🌐 AMSilk is a frontrunner in advanced biomaterials made from silk proteins 🎯 Enabling true change AMSilk's Biogenius Materials made from silk proteins are setting new standards in material innovation. Using cutting-edge science and the most advanced technologies like DNA edition, protein engineering and precision fermentation, we transform biogenic materials inspired by nature into groundbreaking Biongenius Materials. At AMSilk, we turn man-made proteins into formulations, including fibers and yarns, hydrogels and silk powder. The high-performance qualities of our material enable a wide range of applications in the textile, homecare, biomedical, and automobile industries and bring breakthrough benefits for products and …

10 similar entities Type: Startup Activities: deeptech Technologies: New Materials

Accelerate and de-risk medical device development with digital patient twins and simulation Virtonomy introduces v-Patients, enabling medical device developers to perform development and testing in a virtual environment, thereby accelerating development, reducing risks, expenses, and regulatory burden. Our end-to-end digital twin and simulation solution is based on an ever-expanding database of real clinical data to reflect anatomical variability, demographic diversity and pathological conditions. digital health, virtual patients, digital twins, clinical trials, simulation, machine learning, AI, SaaS, simulated trials, cardiac database, and medtech

26 similar entities Type: Startup Activities: healthtech deeptech Technologies: A.I. Data Analytics

Increasing diagnostic quality through the collaboration of medical professionals and AI. deepc is a pioneering company in the realm of Radiology AI, poised to democratize access to health at scale. At the heart of our mission is ourproduct deepcOS®, an unrivaled cloud-native Radiology AI platform. With a vendor-agnostic approach, deepcOS® boasts an expansive repository of cutting-edge AI applications. This groundbreaking platform empowers radiologists to seamlessly include AI insights into their clinical workflows, ushering in a new era of patient care excellence and elevated diagnostic precision. Visit our website now or simply email us at contact@deepc.ai Digital Health, Deep Learning, Machine …

54 similar entities Type: Startup Activities: healthtech it services Technologies: A.I. Data Analytics A.I. - Machine Learning

Unlocking the next generation of mRNA medicines. At Sensible, we are building the best-in-class mRNA design, optimisation and manufacturing platform to unlock the era of mRNA therapeutics and design-based biology.

81 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

A clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies. Inventiva is a clinical-stage biopharmaceutical company focused on the research and development of oral small molecule therapies for the treatment of patients with MASH. Drug Discovery, Biotech, Oncology, Fibrosis, Lysosomal Storage Disorders, NASH, and SSc

63 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Robotics Designed For What Matters. Niryo is a French manufacturer of intelligent robotic solutions, headquartered in the North region of France. We develop a modular robotic platform integrating hardware, software, and embedded intelligence to help professionals and industrial organizations automate repetitive or low value-added tasks with solutions that are accessible and quick to deploy. With more than 4,000 robots deployed across 70 countries, we are also a recognized player in the Education sector through our NED platform, a comprehensive learning ecosystem designed for schools, universities, and training centers in France and internationally. Backed by a team of 50 employees and …

94 similar entities Tags: FrenchTech2030 Type: Startup Activities: industry 4.0 Technologies: Robotics A.I. A.I. - Image Processing IoT

Your strategy deserves the best treatment 100% digital agency specializing in the field of health. Founded in 2008, Interaction Healthcare’s know-how is based on 4 pillars: - digital strategy consulting; - web and social media solutions; - mobile solutions and new interfaces; - digital medical simulation and serious game. Interaction Healthcare designs and develops digital communication and e-training tools for the pharmaceutical industry, university hospitals, simulation centers, learned societies, patient associations, healthcare professionals and the general public. Recognized as an innovative company by the Oséo Excellence 2012 network and partner of INRIa, a digital research laboratory, the agency is developing …

Type: Startup Activities: healthtech edtech Technologies: VR

♫ Global Network of Playlist Tastemakers ♫ Founded in 2014, Soundsgood has now become the leading platform for music influencers. So far, 30,000+ influencers are using Soundsgood to: 1. Create and distribute their playlists to their 120 million followers across Spotify, Apple Music, YouTube, SoundCloud, Deezer, etc. 2. Share and embed universal music players on their website and social networks 3. Grow their follower base and get featured on our media partners 4. Stream the next music releases in early access Open to all, Soundsgood is also used by the best tastemakers like Governors Ball festival, EDM Sauce, Kitsune, Ninja …

Type: Startup Activities: entertainment Technologies: SaaS

Assessment | Coaching | Executive Search | Interim Management GenSearch is a boutique, international executive search and leadership advisory firm focused on the Life Sciences sector. We partner with organisations and senior executives to navigate critical hiring decisions and develop leadership in complex, fast-evolving environments. Our clients value our deep sector expertise, rigorous and transparent processes, and strong ethical foundation. We are known for building trusted, long-term relationships and for our openness in sharing knowledge and networks. Our commitment goes beyond talent – we are proud to have been awarded a Gold rating by EcoVadis, recognising our efforts in sustainability …

41 similar entities Type: Startup Activities: deeptech hrtech healthtech biotech

Credible sustainability & bioeconomy communications. Led by Conscious Business Leader Kathryn Sheridan since 2008. Sustainability Consult is dedicated to raising Credibility and Visibility for organisations worldwide. We are the leading bioeconomy communications and PR agency, based in Brussels, operating internationally. A trusted partner and recognised source for the media, Sustainability Consult has a proven track record in brand building, corporate communications and PR. We offer a full service of high-level consultancy services, from PR to communications and online strategy, through to issues management and crisis communications, as well as events, reports and media monitoring. We tweet @SustConsult. Follow us on …

Type: Media Startup Activities: cleantech greentech martech consulting Technologies: Decarbonization